Scienture Holdings Inc stock is traded at $3.04, with a volume of 6,498. It is up 0.00% in the last 24 hours and down -22.25% over the past month. Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the commercialization and development of products for the treatment of cardiovascular (CVS) and Central Nervous System (CNS) diseases. Scienture LLC launched its first commercial product for hypertension and is in the process of commercializing its second product for the treatment of opioid overdose. Its development pipeline consists of a broad range of novel product candidates including new potential treatments for migraine, thrombosis, pain and other related disorders.
Previous Close:
$3.04
Open:
$3.12
24h Volume:
6,498
Relative Volume:
0.37
Market Cap:
$4.99M
Revenue:
$656.60K
Net Income/Loss:
-$16.79M
P/E Ratio:
-
EPS:
-$1.07
Net Cash Flow:
-$11.12M
1W Performance:
-1.94%
1M Performance:
-22.25%
6M Performance:
-69.44%
1Y Performance:
-82.90%
1-Day Range:
$3.01$3.13
1-Week Range:
$3.01$3.25
52-Week Range:
$2.64$19.47
Scienture Holdings Inc Stock (SCNX) Company Profile
Name
Scienture Holdings IncSector
HealthcareIndustry
Pharmaceutical RetailersPhone
(800) 261 0281Address
20 AUSTIN BLVD., COMMACK, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS